• Modular Learning
  • Resource Database
  • Offerings
    • Partnership Program
    • Seed Fund
    • Modular Learning
    • Resource Database
  • DRIVEN Companies
    DRIVEN Accelerator HubDRIVEN Accelerator Hub
    • Modular Learning
    • Resource Database
    • Offerings
      • Partnership Program
      • Seed Fund
      • Modular Learning
      • Resource Database
    • DRIVEN Companies

      Modular Learning: Operations

      • Home
      • Modular Learning
      • Operations
      Modular LearningOperations
      • Who is the Patient? 4

        • Section1.1
          Introduction
        • Section1.2
          Precision/Personalization, Segmentation, and Incidence/Prevalence
        • Section1.3
          Patient Journey
        • Section1.4
          Expansion/Secondary Indications
      • Standard of Care & Competition 4

        • Section2.1
          Introduction
        • Section2.2
          Unmet Need, Safety, Efficacy, Compliance, Costs
        • Section2.3
          Development Pipeline Analysis/Competitive Intelligence
        • Section2.4
          Competition in Therapeutics (5 forces)
      • Business Model 4

        • Section3.1
          Introduction
        • Section3.2
          Product, Platform or Service
        • Section3.3
          Mission, Vision, Strategy, Tactics, Operations
        • Section3.4
          Who is the Customer?
      • Regulatory 4

        • Section4.1
          Introduction
        • Section4.2
          FDA Introduction
        • Section4.3
          FDA Guidelines
        • Section4.4
          Selecting FDA Consultants
      • Exit/End Goal 4

        • Section5.1
          Introduction
        • Section5.2
          Trade Sales
        • Section5.3
          Sales
        • Section5.4
          Partnerships

        Introduction

        A business model describes how the business creates and captures value. Is it a product or service? Who is the customer? What problem is the business solving for the customer? Who is the payor? Where (geographically) is the opportunity? Etc. The last decades have yielded an explosion in creative business models, most based on Internet businesses. The number of business models in therapeutics development is, however, more limited. The main questions are typically:

        1. Product, platform, or service?
        2. Asset-focused or pipeline-focused?
        3. Virtual or not?
        4. Build to operate or build to sell?
        5. Partner early or late?
        6. Bootstrap, venture, or alternative?
        7. Indication/modality/region/stage of development?

        Resources

        • The McKinsey Way (Structure)
        • The Lean Startup (Operational Excellence)

         

        Prev Competition in Therapeutics (5 forces)
        Next Product, Platform or Service

        driven logo inverted web

        DRIVEN Accelerator Hub   .   info@drivenacceleratorhub.com   .   NIGMS UT2GM13017

        Founded By

        © 2021 DRIVEN Accelerator Hub. All rights reserved.

        Website by RYCO

        Modal title

        Message modal